These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19661370)

  • 1. Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.
    Ralli M; Tourkantonis I; Makrilia N; Gkini E; Kotteas E; Gkiozos I; Katirtzoglou N; Syrigos K
    Anticancer Res; 2009 Aug; 29(8):3441-4. PubMed ID: 19661370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study.
    Tourkantonis I; Makrilia N; Ralli M; Alamara C; Nikolaidis I; Tsimpoukis S; Charpidou A; Kotanidou A; Syrigos K
    Am J Clin Oncol; 2011 Feb; 34(1):38-42. PubMed ID: 20142722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
    van Haarst JM; Baas P; Manegold Ch; Schouwink JH; Burgers JA; de Bruin HG; Mooi WJ; van Klaveren RJ; de Jonge MJ; van Meerbeeck JP
    Br J Cancer; 2002 Feb; 86(3):342-5. PubMed ID: 11875695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma.
    Zucali PA; Ceresoli GL; Garassino I; De Vincenzo F; Cavina R; Campagnoli E; Cappuzzo F; Salamina S; Soto Parra HJ; Santoro A
    Cancer; 2008 Apr; 112(7):1555-61. PubMed ID: 18286536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of the frontline platinum-based combination chemotherapy in malignant peritoneal mesothelioma.
    Kim ST; Park JY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Park SH
    Jpn J Clin Oncol; 2010 Nov; 40(11):1031-6. PubMed ID: 20534685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy management of malignant pleural mesothelioma: a phase II study comparing two popular chemotherapy regimens.
    Habib EE; Fahmy ES
    Clin Transl Oncol; 2013 Nov; 15(11):965-8. PubMed ID: 23408040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
    Toyokawa G; Takenoyama M; Hirai F; Toyozawa R; Inamasu E; Kojo M; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
    Int J Clin Oncol; 2014 Aug; 19(4):601-6. PubMed ID: 24158772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma.
    Nowak AK; Byrne MJ; Williamson R; Ryan G; Segal A; Fielding D; Mitchell P; Musk AW; Robinson BW
    Br J Cancer; 2002 Aug; 87(5):491-6. PubMed ID: 12189542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cisplatin plus pemetrexed and cisplatin plus gemcitabine for the treatment of malignant pleural mesothelioma in Japanese patients.
    Shukuya T; Takahashi T; Imai H; Tokito T; Ono A; Akamatsu H; Taira T; Kenmotsu H; Naito T; Murakami H; Endo M; Yamamoto N
    Respir Investig; 2014 Mar; 52(2):101-6. PubMed ID: 24636265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
    Pasello G; Nicotra S; Marulli G; Rea F; Bonanno L; Carli P; Magro C; Jirillo A; Favaretto A
    Lung Cancer; 2011 Sep; 73(3):351-5. PubMed ID: 21296448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma.
    Kovac V; Zwitter M; Rajer M; Marin A; Debeljak A; Smrdel U; Vrankar M
    Anticancer Drugs; 2012 Feb; 23(2):230-8. PubMed ID: 22027538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study.
    Favaretto AG; Aversa SM; Paccagnella A; Manzini Vde P; Palmisano V; Oniga F; Stefani M; Rea F; Bortolotti L; Loreggian L; Monfardini S
    Cancer; 2003 Jun; 97(11):2791-7. PubMed ID: 12767092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epirubicin and gemcitabine as first-line treatment in malignant pleural mesothelioma.
    Portalone L; Antilli A; Nunziati F; Crispino C; de Marinis F; Friggeri L; Lombardi A; Lorusso V; Pronzato P; Sambiasi D; Signora M;
    Tumori; 2005; 91(1):15-8. PubMed ID: 15849999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma. A multicenter Italian Phase II Study (SITMP1).
    Pinto C; Marino A; De Pangher Manzini V; Benedetti G; Galetta D; Mazzanti P; Del Conte G; dell'Amore D; Piana E; Giaquinta S; Lopez M; Martoni A
    Lung Cancer; 2006 May; 52(2):199-206. PubMed ID: 16542747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
    Jänne PA; Simon GR; Langer CJ; Taub RN; Dowlati A; Fidias P; Monberg M; Obasaju C; Kindler H
    J Clin Oncol; 2008 Mar; 26(9):1465-71. PubMed ID: 18349397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
    Simon GR; Verschraegen CF; Jänne PA; Langer CJ; Dowlati A; Gadgeel SM; Kelly K; Kalemkerian GP; Traynor AM; Peng G; Gill J; Obasaju CK; Kindler HL
    J Clin Oncol; 2008 Jul; 26(21):3567-72. PubMed ID: 18640937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810).
    Kalmadi SR; Rankin C; Kraut MJ; Jacobs AD; Petrylak DP; Adelstein DJ; Keohan ML; Taub RN; Borden EC
    Lung Cancer; 2008 May; 60(2):259-63. PubMed ID: 18006112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia.
    Lee CW; Murray N; Anderson H; Rao SC; Bishop W
    Lung Cancer; 2009 Jun; 64(3):308-13. PubMed ID: 19004520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of First-Line Chemotherapeutics and Validation of the EORTC Prognostic Index in Malignant Pleural Mesothelioma: Retrospective Single-Centre Experience.
    Sezgin Y; Karhan O; Ileri S; Ebinc S; Tunc S; Urakci Z
    J Coll Physicians Surg Pak; 2024 Aug; 34(8):904-909. PubMed ID: 39113507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
    Okuno SH; Delaune R; Sloan JA; Foster NR; Maurer MJ; Aubry MC; Rowland KM; Soori GS; Nikcevich DA; Kardinal CG; Northfelt DW; Adjei AA;
    Cancer; 2008 Apr; 112(8):1772-9. PubMed ID: 18224661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.